CSF TNF and osteopontin levels correlate with the response to dimethyl fumarate in early multiple sclerosis

Background: Disease activity in the first years after a diagnosis of relapsing-remitting multiple sclerosis (RRMS) is a negative prognostic factor for long-term disability. Markers of both clinical and radiological responses to disease-modifying therapies (DMTs) are advocated. Objective: The objecti...

Celý popis

Uložené v:

Podrobná bibliografia
Vydané v:	Therapeutic advances in neurological disorders Ročník 15; s. 17562864221092124
Hlavní autori:	Marastoni, Damiano, Pisani, Anna I., Schiavi, Gianmarco, Mazziotti, Valentina, Castellaro, Marco, Tamanti, Agnese, Bosello, Francesca, Crescenzo, Francesco, Ricciardi, Giuseppe K., Montemezzi, Stefania, Pizzini, Francesca B., Calabrese, Massimiliano
Médium:	Journal Article
Jazyk:	English
Vydavateľské údaje:	London, England SAGE Publications 2022 SAGE PUBLICATIONS, INC SAGE Publishing
Predmet:	APRIL protein CD163 antigen Cerebrospinal fluid Chemokines CXCL12 protein CXCL13 protein Demography Diagnosis Inflammation Interleukin 12 Ligands Lymphocytes B Magnetic resonance imaging Multiple sclerosis Original Research Osteopontin Patients Substantia alba Substantia grisea Tumor necrosis factor Tumor necrosis factor-TNF Tumors γ-Interferon relapsing multiple sclerosis osteopontin disease activity cytokines dimethyl fumarate chemokines TNF
ISSN:	1756-2864, 1756-2856, 1756-2864
On-line prístup:	Získať plný text
Tagy:	Pridať tag Žiadne tagy, Buďte prvý, kto otaguje tento záznam!

Buďte prvý, kto okomentuje tento záznam!